Objective: To explore the application of computed tomography (CT) and magnetic resonance imaging (MRI) in combination with vascular endothelial growth factor-C (VEGF-C) and epidermal growth factor receptor (EGFR) in the identification of endometrial cancer stages.
Methods: Clinical data of 84 patients with endometrial cancer who underwent surgery in our hospital were retrospectively analyzed. Before surgery, they were received inspection by CT and MRI and examination by VEGF-C and EGFR measurement.